• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经蝶窦内镜手术治疗Knosp 4级垂体腺瘤积极切除策略的疗效及并发症

Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy.

作者信息

Ouyang Taohui, Zhang Na, Xie Shenhao, Tang Bin, Li Junjun, Xiao Limin, Zhang Fabao, Wu Bowen, Zhou Dongwei, Li Meihua, Hong Tao

机构信息

Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.

Department of Neurology, the First Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Front Oncol. 2021 Jun 21;11:693063. doi: 10.3389/fonc.2021.693063. eCollection 2021.

DOI:10.3389/fonc.2021.693063
PMID:34235083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8255811/
Abstract

Surgery for pituitary adenomas (PAs) with cavernous sinus (CS) invasion in Knosp grade 4 is a great challenge and whether to adopt a conservative or aggressive surgical strategy is controversial. The aim of this study is to provide the outcomes and complications of an aggressive resection strategy for Knosp grade 4 PAs with transsphenoidal endoscopic surgery. Outcomes and complications were retrospectively analyzed in 102 patients with Knosp grade 4 PAs. Among them, primary PAs were seen in 60 patients and recurrent PAs were seen in 42 cases. Gross total resection (GTR) of the entire tumor was achieved in 72 cases (70.6%), subtotal tumor resection (STR) in 18 cases (17.6%), and partial tumor resection (PTR) in 12 cases (11.8%). Additionally, GTR of the tumor within the CS was achieved in 82 patients (80.4%), STR in 17 patients (16.7%), and PTR in 3 patients (2.9%). Statistical analyses showed that both recurrent tumors and firm consistency tumors were adverse factors for complete resection (P<0.05). Patients with GTR of the entire tumor were more likely to have favorable endocrine and visual outcomes than those with incomplete resection (P<0.05). Overall, the most common surgical complication was new cranial nerve palsy (n=7, 6.8%). The incidence of internal carotid artery (ICA) injury and postoperative cerebrospinal fluid (CSF) leakage was 2.0% (n=2) and 5.9% (n=6), respectively. Six patients (5.9%) experienced tumor recurrence postoperatively. For experienced neuroendoscopists, an aggressive tumor resection strategy transsphenoidal endoscopic surgery may be an effective and safe option for Knosp grade 4 PAs.

摘要

对于Knosp 4级海绵窦(CS)侵袭性垂体腺瘤(PA)的手术是一项巨大挑战,采用保守还是积极的手术策略存在争议。本研究旨在提供经蝶窦内镜手术对Knosp 4级PA采取积极切除策略的结果及并发症。对102例Knosp 4级PA患者的结果及并发症进行回顾性分析。其中,60例为原发性PA,42例为复发性PA。72例(70.6%)实现了肿瘤全切除(GTR),18例(17.6%)为次全肿瘤切除(STR),12例(11.8%)为部分肿瘤切除(PTR)。此外,82例(80.4%)患者实现了CS内肿瘤的GTR,17例(16.7%)为STR,3例(2.9%)为PTR。统计分析表明,复发性肿瘤和质地硬的肿瘤均为完全切除的不利因素(P<0.05)。肿瘤全切除的患者比未完全切除的患者更有可能获得良好的内分泌和视力结果(P<0.05)。总体而言,最常见的手术并发症是新发脑神经麻痹(n = 7,6.8%)。颈内动脉(ICA)损伤和术后脑脊液(CSF)漏的发生率分别为2.0%(n = 2)和5.9%(n = 6)。6例(5.9%)患者术后出现肿瘤复发。对于经验丰富的神经内镜医师,经蝶窦内镜手术采取积极的肿瘤切除策略可能是Knosp 4级PA的一种有效且安全的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d709/8255811/73614c8694dd/fonc-11-693063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d709/8255811/709b7da3ae5e/fonc-11-693063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d709/8255811/73614c8694dd/fonc-11-693063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d709/8255811/709b7da3ae5e/fonc-11-693063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d709/8255811/73614c8694dd/fonc-11-693063-g002.jpg

相似文献

1
Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy.经蝶窦内镜手术治疗Knosp 4级垂体腺瘤积极切除策略的疗效及并发症
Front Oncol. 2021 Jun 21;11:693063. doi: 10.3389/fonc.2021.693063. eCollection 2021.
2
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
3
Extended transsphenoidal approach for pituitary adenomas invading the cavernous sinus using multiple complementary techniques.采用多种辅助技术的扩大经蝶入路治疗侵袭海绵窦的垂体腺瘤
Pituitary. 2016 Feb;19(1):1-10. doi: 10.1007/s11102-015-0675-0.
4
Endoscopic endonasal surgery for nonadenomatous, nonmeningeal pathology involving the cavernous sinus.经鼻内镜颅底手术治疗涉及海绵窦的非腺瘤性、非脑膜性病变。
J Neurosurg. 2017 Mar;126(3):880-888. doi: 10.3171/2015.8.JNS15275. Epub 2016 Apr 29.
5
Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.经鼻内镜垂体腺瘤术后残留或复发的再次手术治疗。
J Neurosurg. 2017 Aug;127(2):397-408. doi: 10.3171/2016.8.JNS152709. Epub 2016 Oct 28.
6
Extent of Resection, Visual, and Endocrinologic Outcomes for Endoscopic Endonasal Surgery for Recurrent Pituitary Adenomas.复发性垂体腺瘤经鼻内镜手术的切除范围、视觉及内分泌学结果
World Neurosurg. 2017 Jun;102:35-41. doi: 10.1016/j.wneu.2017.02.131. Epub 2017 Mar 9.
7
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.内镜经蝶窦手术治疗肢端肥大症患者中肿瘤特征及术前术后激素水平对激素缓解的影响。
Neurosurg Focus. 2020 Jun;48(6):E10. doi: 10.3171/2020.3.FOCUS2080.
8
Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus.内镜经蝶窦切除术治疗侵犯海绵窦的垂体腺瘤
Zh Vopr Neirokhir Im N N Burdenko. 2016;80(4):63-74. doi: 10.17116/neiro201680463-74.
9
Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.对单一机构中Knosp 0-2级无功能垂体大腺瘤的显微手术与内镜经蝶窦手术同期系列病例进行回顾性分析。
J Neurosurg. 2014 Sep;121(3):511-7. doi: 10.3171/2014.6.JNS131321. Epub 2014 Jul 4.
10
Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis.经内镜经蝶窦手术治疗复发性或残留垂体腺瘤的疗效分析,并与倾向性评分分析的非复发性或残留患者队列进行比较。
Front Endocrinol (Lausanne). 2022 Apr 25;13:837025. doi: 10.3389/fendo.2022.837025. eCollection 2022.

引用本文的文献

1
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study.鼻中隔偏曲对经鼻内镜蝶窦手术疗效的影响:一项基于人群的研究。
Pituitary. 2025 May 17;28(3):61. doi: 10.1007/s11102-025-01531-2.
2
Multi-center application of a convolutional neural network for preoperative detection of cavernous sinus invasion in pituitary adenomas.卷积神经网络在垂体腺瘤海绵窦侵犯术前检测中的多中心应用
Neuroradiology. 2024 Mar;66(3):353-360. doi: 10.1007/s00234-024-03287-1. Epub 2024 Jan 18.
3
Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review.

本文引用的文献

1
Pituitary adenoma with posterior area invasion of cavernous sinus: surgical anatomy, approach, and outcomes.侵犯海绵窦后部区域的垂体腺瘤:手术解剖、入路及结果
Neurosurg Rev. 2021 Aug;44(4):2229-2237. doi: 10.1007/s10143-020-01404-1. Epub 2020 Oct 2.
2
Relationship between pneumatization of lateral recess in the sphenoid sinus and removal of cavernous sinus invasion in pituitary adenomas by endoscopic endonasal surgery.蝶窦外侧隐窝气化与经鼻内镜手术切除垂体腺瘤海绵窦侵犯之间的关系
Surg Neurol Int. 2019 Nov 15;10:222. doi: 10.25259/SNI_169_2019. eCollection 2019.
3
Surgical Treatment of Cavernous Sinus Lesion in Patients with Nonfunctioning Pituitary Adenomas via the Endoscopic Endonasal Approach.
生长激素和催乳素分泌型垂体神经内分泌肿瘤的预后模型:一项系统综述
Diagnostics (Basel). 2023 Jun 19;13(12):2118. doi: 10.3390/diagnostics13122118.
4
Advances in surgical approaches for refractory pituitary adenomas.难治性垂体腺瘤的手术治疗进展。
Pituitary. 2023 Jun;26(3):293-297. doi: 10.1007/s11102-023-01318-3. Epub 2023 Apr 28.
5
Surgical Experience of Transcranial Approaches to Large-to-Giant Pituitary Adenomas in Knosp Grade 4.经颅入路切除 Knosp 分级 4 级大/巨大垂体腺瘤的手术经验。
Front Endocrinol (Lausanne). 2022 May 12;13:857314. doi: 10.3389/fendo.2022.857314. eCollection 2022.
6
Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas.垂体腺瘤术后复发预后模型的建立与验证
Front Oncol. 2022 Apr 28;12:882049. doi: 10.3389/fonc.2022.882049. eCollection 2022.
7
The Clinical and Pathological Characteristics of Refractory Pituitary Adenomas: A Single Center Experience.难治性垂体腺瘤的临床与病理特征:单中心经验
Front Oncol. 2022 Mar 16;12:846614. doi: 10.3389/fonc.2022.846614. eCollection 2022.
8
Radiological Knosp, Revised-Knosp, and Hardy-Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases.垂体腺瘤内镜鼻内手术中用于预测手术结果的放射学Knosp、修订Knosp和Hardy-Wilson分类:228例研究
Front Oncol. 2022 Jan 20;11:807040. doi: 10.3389/fonc.2021.807040. eCollection 2021.
经鼻内镜入路手术治疗无功能垂体腺瘤患者海绵窦病变
J Neurol Surg B Skull Base. 2018 Oct;79(Suppl 4):S311-S315. doi: 10.1055/s-0038-1667123. Epub 2018 Jul 16.
4
A Consensus Statement on acromegaly therapeutic outcomes.肢端肥大症治疗结局的共识声明
Nat Rev Endocrinol. 2018 Sep;14(9):552-561. doi: 10.1038/s41574-018-0058-5.
5
Cavernous sinus compartments from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery.经鼻内镜入路海绵窦间隙:解剖学考虑因素及其与腺瘤手术的相关性。
J Neurosurg. 2018 Aug;129(2):430-441. doi: 10.3171/2017.2.JNS162214. Epub 2017 Sep 1.
6
Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System.基于改良Knosp分级系统的海绵窦侵袭性无功能垂体腺瘤的治疗策略
Brain Tumor Res Treat. 2016 Oct;4(2):63-69. doi: 10.14791/btrt.2016.4.2.63. Epub 2016 Oct 31.
7
Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus.内镜经蝶窦切除术治疗侵犯海绵窦的垂体腺瘤
Zh Vopr Neirokhir Im N N Burdenko. 2016;80(4):63-74. doi: 10.17116/neiro201680463-74.
8
Endoscopic endonasal management of non-functioning pituitary adenomas with cavernous sinus invasion: a 10- year experience.内镜经鼻蝶窦入路治疗侵袭海绵窦的无功能垂体腺瘤:10 年经验。
Rhinology. 2015 Dec;53(4):308-16. doi: 10.4193/Rhino14.309.
9
Extended transsphenoidal approach for pituitary adenomas invading the cavernous sinus using multiple complementary techniques.采用多种辅助技术的扩大经蝶入路治疗侵袭海绵窦的垂体腺瘤
Pituitary. 2016 Feb;19(1):1-10. doi: 10.1007/s11102-015-0675-0.
10
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.库欣综合征的治疗:美国内分泌学会临床实践指南
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.